{"id":13022,"date":"2008-05-30T12:51:17","date_gmt":"2008-05-30T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=13022"},"modified":"2018-03-11T11:21:45","modified_gmt":"2018-03-11T17:21:45","slug":"13022","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/13022\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 30 de maio de 2008"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN-5-30-08.pdf\">vers\u00e3o para impress\u00e3o<\/a><\/p>\n<p>*******************************************************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas de sa\u00fade animal de 30 de maio de 2008<\/strong><br \/>\nCopyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon, DVM, MBA <br \/>\n*******************************************************************<br \/>\nPULE PARA:<br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de ganhos<\/u><br \/>\nRidley<br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<\/u><br \/>\nBotic\u00e1rios<br \/>\nBioTracking<br \/>\nceva<br \/>\nDechra<br \/>\nNovartis<br \/>\nnutri-veterin\u00e1ria<br \/>\nPet DRx<br \/>\nFibro<br \/>\nVCA Antech<br \/>\nVetXX<br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nRELEASES DE RESULTADOS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Ridley Inc. divulgou os resultados financeiros de seu terceiro trimestre fiscal de 2008 encerrado em 31 de mar\u00e7o de 2008. Para o trimestre, a empresa reportou receita l\u00edquida de $5,0 milh\u00f5es em compara\u00e7\u00e3o com receita l\u00edquida de $3,1 milh\u00f5es no mesmo per\u00edodo do ano anterior. As receitas para o terceiro trimestre do ano fiscal de 2008 foram de $167 milh\u00f5es em compara\u00e7\u00e3o com as receitas de $137 milh\u00f5es no mesmo per\u00edodo do ano anterior. (site da companhia)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Novartis Animal Health US, Inc. introduziu o Neporex 2SG aprovado pela EPA para o controle de larvas de moscas multiesp\u00e9cies em opera\u00e7\u00f5es de cavalos, su\u00ednos, bovinos e aves. Neporex interrompe o crescimento larval e impede o desenvolvimento de moscas adultas para melhorar a higiene da fazenda. (Rede Gado)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A Nutri-vet, LLC e a Ceva Sant\u00e9 Animale concordaram em resolver uma a\u00e7\u00e3o judicial envolvendo patentes e quest\u00f5es da Lei Lantham. A Ceva continuar\u00e1 com sua linha de produtos para animais de estima\u00e7\u00e3o \u00e0 base de ferom\u00f4nios, enquanto a Nutri-Vet apresentar\u00e1 sua nova linha de produtos calmantes para animais de estima\u00e7\u00e3o \u00e0 base de ervas. (comunicado de imprensa da empresa)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A Phibro Animal Health Corporation anunciou que Larry Miller ingressou na empresa como Presidente de Sa\u00fade e Nutri\u00e7\u00e3o Animal. As responsabilidades globais do Sr. Miller incluir\u00e3o a Phibro Animal Health Division e a Prince Agriproducts. (eMediawire)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A Dechra Pharmaceuticals anunciou a aquisi\u00e7\u00e3o da VetXX. A aquisi\u00e7\u00e3o aumenta a gama de produtos da Dechra e expande a presen\u00e7a da Dechra em oito pa\u00edses europeus, al\u00e9m do Reino Unido e Irlanda. Os termos financeiros n\u00e3o foram divulgados. (site da companhia)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Pet DRx Corporation anunciou que suas a\u00e7\u00f5es ordin\u00e1rias, warrants e unidades come\u00e7ar\u00e3o a ser negociadas no Nasdaq Capital Market sob os s\u00edmbolos \u201cVETS\u201d, \u201cVETSW\u201d e \u201cVETSU\u201d respectivamente, quando o mercado abrir em 29 de maio de 2008. Pet DRx a\u00e7\u00f5es, warrants e unidades anteriormente negociadas no OTC Bulletin Board. (Corre\u00e7\u00e3o Comercial)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A BioTracking, LLC, anunciou que os testes para o v\u00edrus da Artrite-Encefalite Caprina (CAE) e da Diarr\u00e9ia Viral Bovina (BVD) est\u00e3o agora dispon\u00edveis em seu laborat\u00f3rio em Moscou, Idaho. Esses novos testes s\u00e3o uma adi\u00e7\u00e3o ao teste de gravidez BioPRYN da empresa e podem ser avaliados usando as mesmas amostras de sangue enviadas para diagn\u00f3stico de gravidez. (comunicado de imprensa da empresa) <br \/>\n&nbsp;<br \/>\n&gt; VCA Antech anunciou que The Apothecary Shops assinou um contrato para ser o fornecedor do PhaSeal, o \u00fanico dispositivo de transfer\u00eancia de medicamentos de sistema fechado clinicamente comprovado do pa\u00eds, para mais de 400 VCA Animal Hospitals. O Sistema PhaSeal \u00e9 \u00fanico na medida em que evita a libera\u00e7\u00e3o de contaminantes e vapores e aeross\u00f3is de medicamentos perigosos resultantes da mistura de produtos qu\u00edmicos usados para quimioterapia intravenosa para animais. (comunicado de imprensa da empresa)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 LIVESTOCK FEED O USDA anunciou que autorizou 24 milh\u00f5es de acres atualmente sob o Conservation Reserve Program (CRP) para feno e forragem para alimentar o gado neste ver\u00e3o para ajudar os produtores a lidar com os altos pre\u00e7os dos alimentos e poss\u00edvel escassez de gr\u00e3os. Agricultores e pecuaristas com \u00e1rea CRP ser\u00e3o cobrados $75 pelo processamento, mas n\u00e3o ser\u00e3o avaliados qualquer redu\u00e7\u00e3o no pagamento do aluguel para feno ou pastagem da terra. O programa, no entanto, n\u00e3o permite que os produtores saiam antecipadamente de seus contratos do CRP para cultivar gr\u00e3os naquela terra. (Local de Refei\u00e7\u00e3o)<br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 MUDAN\u00c7AS CLIM\u00c1TICAS Um novo relat\u00f3rio do US Climate Change Science Program, \u201cSynthesis and Assessment Product 4.3 (SAP 4.3): The Effects of Climate Change on Agriculture, Land Resources, Water Resources, and Biodiversity in the United States,\u201d relata que a mudan\u00e7a clim\u00e1tica est\u00e1 afetando a produ\u00e7\u00e3o pecu\u00e1ria e continuar\u00e1 a faz\u00ea-lo. O USDA \u00e9 a ag\u00eancia l\u00edder do relat\u00f3rio, que foi escrito por 38 autores de universidades, laborat\u00f3rios nacionais, organiza\u00e7\u00f5es n\u00e3o-governamentais e servi\u00e7os federais. As descobertas incluem: (1) temperaturas mais altas afetar\u00e3o negativamente o gado. Invernos mais quentes reduzir\u00e3o a mortalidade, mas isso ser\u00e1 mais do que compensado por uma maior mortalidade nos ver\u00f5es mais quentes; (2) temperaturas mais altas tamb\u00e9m resultar\u00e3o em produtividade reduzida de gado e animais leiteiros; (3) as safras de gr\u00e3os e oleaginosas amadurecer\u00e3o mais rapidamente, mas o aumento das temperaturas aumentar\u00e1 o risco de quebra de safra, principalmente se a precipita\u00e7\u00e3o diminuir ou se tornar mais vari\u00e1vel; e (4) a esta\u00e7\u00e3o de crescimento aumentou de 10 a 14 dias nos \u00faltimos 19 anos nas latitudes temperadas. A distribui\u00e7\u00e3o das esp\u00e9cies tamb\u00e9m mudou. Para ver o relat\u00f3rio completo, acesse <a href=\"http:\/\/www.climatescience.gov\/Library\/sap\/sap4-3\/default.php\">http:\/\/www.climatescience.gov\/Library\/sap\/sap4-3\/default.php<\/a> <br \/>\n&nbsp;<br \/>\n******************************************************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<br \/>\n&nbsp;<br \/>\nA lista de not\u00edcias desta curta semana \u00e9 um pouco breve, o que nos permite comentar algumas outras \u00e1reas.&nbsp; <br \/>\n&nbsp;<br \/>\nEstamos animados com o n\u00famero de novas empresas e projetos de pesquisa que est\u00e3o se desenvolvendo na \u00e1rea de sa\u00fade animal. Nos \u00faltimos meses fomos contatados por in\u00fameras empresas ou indiv\u00edduos com interesse no desenvolvimento de novas tecnologias que resultar\u00e3o em novos produtos comerciais nos pr\u00f3ximos anos.&nbsp; <br \/>\n&nbsp;<br \/>\nGrande parte dessa atividade aumentada est\u00e1 sendo alimentada pelo interesse geral da comunidade financeira nos setores de sa\u00fade animal e animais de estima\u00e7\u00e3o. Os fundos de a\u00e7\u00f5es alimentaram parte dessa atividade aumentando as avalia\u00e7\u00f5es das empresas atuais, principalmente se elas tiverem um forte invent\u00e1rio de PI.&nbsp; <br \/>\n&nbsp;<br \/>\nEmbora possa ser um pouco mais dif\u00edcil, sob as atuais condi\u00e7\u00f5es financeiras, expandir os atuais investimentos em pesquisa, novas tecnologias continuar\u00e3o a impulsionar o crescimento da ind\u00fastria no futuro. A alavancagem de financiamento externo \u00e0 ind\u00fastria para criar novas tecnologias torna-se um aspecto cada vez mais importante para o crescimento da ind\u00fastria.&nbsp; <br \/>\n&nbsp;<br \/>\nTenha um \u00f3timo fim de semana!!<br \/>\n&nbsp;<br \/>\nRon Brakke<br \/>\n&nbsp;<br \/>\n*******************************************************************<br \/>\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<br \/>\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n2735 Villa Creek, Su\u00edte 140<br \/>\nDallas, TX 75234 EUA<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>vers\u00e3o para impress\u00e3o ******************************************************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 30 de maio de 2008 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ******************************************************************** IR PARA: not\u00edcias sobre lucros Ridley outras not\u00edcias Botic\u00e1rios BioTracking Ceva Dechra Novartis Nutri-vet Pet DRx Phibro VCA Antech VetXX *********************************************************************** DIVULGA\u00c7\u00d5ES DE RESULTADOS DA EMPRESA &gt; A Ridley Inc. divulgou os resultados financeiros do terceiro trimestre fiscal de 2008, encerrado em 31 de mar\u00e7o de 2008. No trimestre, a empresa divulgou lucros l\u00edquidos de $5,0 milh\u00f5es, em compara\u00e7\u00e3o com lucros l\u00edquidos de $3,1 milh\u00f5es no mesmo per\u00edodo do ano passado. As receitas do terceiro trimestre do ano fiscal de 2008 foram de $167 milh\u00f5es, em compara\u00e7\u00e3o com as receitas de $137 milh\u00f5es no per\u00edodo compar\u00e1vel do ano anterior. (site da empresa) ******************************************************************** COMUNICADOS \u00c0 IMPRENSA DA EMPRESA &gt; A Novartis Animal Health US, Inc. introduziu o Neporex 2SG aprovado pela EPA para controle de larvas de moscas de v\u00e1rias esp\u00e9cies em opera\u00e7\u00f5es de cavalos, porcos, gado e aves. O Neporex interrompe o crescimento larval e previne o desenvolvimento de moscas adultas para melhorar a higiene da fazenda. (CattleNetwork) &gt; A Nutri-vet, LLC e a Ceva Sant\u00e9 Animale concordaram em resolver um processo judicial envolvendo quest\u00f5es de patentes e da Lei Lantham. A Ceva continuar\u00e1 com sua linha de produtos de comportamento para animais de estima\u00e7\u00e3o \u00e0 base de ferom\u00f4nios, enquanto a Nutri-Vet apresentar\u00e1 sua nova linha de produtos calmantes para animais de estima\u00e7\u00e3o \u00e0 base de ervas. (comunicado \u00e0 imprensa da empresa) &gt; A Phibro Animal Health Corporation anunciou que Larry Miller se juntou \u00e0<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/13022\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-13022","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/13022\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ******************************************************************* Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 30, 2008 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* JUMP TO: &nbsp; earnings news Ridley &nbsp; other news Apothecary Shops BioTracking Ceva Dechra Novartis Nutri-vet Pet DRx Phibro VCA Antech VetXX &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt; Ridley Inc. reported financial results for its fiscal 2008 third quarter ended March 31, 2008.&nbsp; For the quarter, the company reported net earnings of $5.0 million compared to net earnings of $3.1 million for the same period last year. Revenues for the third quarter of fiscal 2008 were $167 million compared to revenues of $137 million in the comparable prior-year period.&nbsp; (company website)&nbsp;&nbsp; &nbsp; ******************************************************************* COMPANY NEWS RELEASES &nbsp; &gt; Novartis Animal Health US, Inc. introduced EPA approved Neporex 2SG for multi-species fly larvae control for horse, pig, cattle and poultry operations.&nbsp; Neporex halts larval growth and prevents adult fly development for improved farm hygiene. (CattleNetwork)&nbsp;&nbsp; &nbsp; &gt; Nutri-vet, L.L.C., and Ceva Sant\u00e9 Animale have jointly agreed to resolve a lawsuit involving patent and Lantham Act issues. Ceva will continue with its line of pheromone-based pet-behavior products, while Nutri-Vet will introduce its new line of herbal-based pet-calming products. (company press release)&nbsp;&nbsp; &nbsp; &gt; Phibro Animal Health Corporation announced that Larry Miller has joined theView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/13022\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2008-05-30T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-11T17:21:45+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for May 30, 2008\",\"datePublished\":\"2008-05-30T17:51:17+00:00\",\"dateModified\":\"2018-03-11T17:21:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/\"},\"wordCount\":1024,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2008-05-30T17:51:17+00:00\",\"dateModified\":\"2018-03-11T17:21:45+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/ja\/13022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/13022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for May 30, 2008\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/13022\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ******************************************************************* Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 30, 2008 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* JUMP TO: &nbsp; earnings news Ridley &nbsp; other news Apothecary Shops BioTracking Ceva Dechra Novartis Nutri-vet Pet DRx Phibro VCA Antech VetXX &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt; Ridley Inc. reported financial results for its fiscal 2008 third quarter ended March 31, 2008.&nbsp; For the quarter, the company reported net earnings of $5.0 million compared to net earnings of $3.1 million for the same period last year. Revenues for the third quarter of fiscal 2008 were $167 million compared to revenues of $137 million in the comparable prior-year period.&nbsp; (company website)&nbsp;&nbsp; &nbsp; ******************************************************************* COMPANY NEWS RELEASES &nbsp; &gt; Novartis Animal Health US, Inc. introduced EPA approved Neporex 2SG for multi-species fly larvae control for horse, pig, cattle and poultry operations.&nbsp; Neporex halts larval growth and prevents adult fly development for improved farm hygiene. (CattleNetwork)&nbsp;&nbsp; &nbsp; &gt; Nutri-vet, L.L.C., and Ceva Sant\u00e9 Animale have jointly agreed to resolve a lawsuit involving patent and Lantham Act issues. Ceva will continue with its line of pheromone-based pet-behavior products, while Nutri-Vet will introduce its new line of herbal-based pet-calming products. (company press release)&nbsp;&nbsp; &nbsp; &gt; Phibro Animal Health Corporation announced that Larry Miller has joined theView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/13022\/","og_site_name":"Brakke Consulting Website","article_published_time":"2008-05-30T17:51:17+00:00","article_modified_time":"2018-03-11T17:21:45+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/ja\/13022\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/13022\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for May 30, 2008","datePublished":"2008-05-30T17:51:17+00:00","dateModified":"2018-03-11T17:21:45+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/ja\/13022\/"},"wordCount":1024,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/ja\/13022\/","url":"https:\/\/brakkeconsulting.com\/ja\/13022\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2008-05-30T17:51:17+00:00","dateModified":"2018-03-11T17:21:45+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/ja\/13022\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/ja\/13022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/ja\/13022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for May 30, 2008"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/13022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=13022"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/13022\/revisions"}],"predecessor-version":[{"id":13057,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/13022\/revisions\/13057"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=13022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=13022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=13022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}